Technologies

We aim to have near-term impact in the world by developing groundbreaking bioinspired technologies, ranging from novel devices and materials to high-value therapeutics and diagnostics, that are translated into commercial products and solutions. If you are interested in any of these technologies, please contact us.

Diagnostics

Therapeutics

MedTech

Sustainability

Women's Health

Girl getting piggyback with mother and grandmother in garden

Opportunity Type:

Startup Licensing Collaboration Philanthropic

Diagnostic

NeoSense: Sepsis Detection in Newborns

NeoSense is a new test that uses a tiny sample of saliva instead of blood, powered by advanced single-molecule detection and AI.

Portrait of a senior woman with inhaller, healthcare concept. Close-up of senior woman patient receiving oxygen mask.

Triage test for COPD patients

COPDx: Rapid diagnostic to triage acute exacerbations

A point-of-care test based on new biomarkers to rapidly identify COPD patients who are high risk of acute exacerbations (AEs), determine the cause, and guide treatment.

Rapid triage test for blood clots

Blood Clot Dx

An ultra-sensitive triage test that identifies patients at risk for blood clots before they happen, enabling proactive treatment to reduce complications and deaths across a wide range of conditions.

Muscle healing hydrogel adhesive

Injectable Hydrogel Adhesive for Improved Muscle Regeneration

A super-strong, stretchy, and self-healing biomaterial that adheres to muscles and helps them heal faster after injury.

3D illustration. atom connection concept. Abstrack background. Science Wallpaper screensaver

DNA-based proteomics

DNA Nanoswitch Calipers for Single-Molecule Proteomics

DNA nanoswitch calipers are a first-of-their-kind research tool that leverage DNA’s unique molecular qualities to study post-translational modifications on proteins to unlock a new frontier of medicine.

DNA origami-based immunotherapies

DoriVac: DNA Origami-Based Vaccines for Combination Immunotherapy

Personalized cancer and infectious disease vaccine platform harnessing DNA nanotechnology to control the co-delivery and co-presentation of tumor antigen and adjuvant ligands to immune cells with nanoscale precision. This approach has potential to trigger enhanced immune responses against tumors and infectious pathogens.